Parma, Italy

Laura Carzaniga

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Laura Carzaniga: Innovator in Pharmaceutical Science

Introduction

Laura Carzaniga is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target specific receptors in the body. With a total of 10 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents are innovative compounds that exhibit both muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity. These compounds are defined by specific formulas and are designed to be useful in the prevention and treatment of broncho-obstructive or inflammatory diseases. The dual action of these compounds makes them particularly valuable in addressing complex medical conditions.

Career Highlights

Laura Carzaniga is currently employed at Chiesi Farmaceutici S.p.A., a company known for its commitment to developing innovative pharmaceutical solutions. Her work at Chiesi has allowed her to focus on creating effective treatments that can improve patient outcomes.

Collaborations

Throughout her career, Laura has collaborated with notable colleagues, including Fabio Rancati and Andrea Rizzi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Laura Carzaniga's contributions to pharmaceutical science through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in the treatment of respiratory and inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…